Status:
WITHDRAWN
The Role of Disc Nutrition in the Etiology and Clinical Treatment of Disc Degeneration
Lead Sponsor:
VA Office of Research and Development
Conditions:
Back Pain
Intervertebral Disc Degeneration
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
The purpose of this research study is to examine the effects of physical therapy on the spinal discs. Back pain is the number one cause of disability in the US, and the spine is the most common locati...
Detailed Description
Low back pain, which is frequently associated with intervertebral disc degeneration, is the most common cause of adult disability in the United States. Among active service members, the incidence of d...
Eligibility Criteria
Inclusion
- Current activity limiting low back pain
- With symptoms of any duration
- With or without symptoms extending distal to the buttocks
- Medically stable
- Candidate for physical therapy
Exclusion
- Documented history of prior spinal surgery
- Contraindications to MRI including:
- claustrophobia
- pregnancy
- implanted electronic devices
- pacemakers, cochlear implant, insulin pumps, etc
- metallic foreign bodies
- i.e. shrapnel
- documented history of contraindications to gadodiamide (Omniscan) administration:
- chronic severe kidney disease
- acute kidney injury
- impaired elimination of gadolinium based contrast agents
- pre-existing renal insufficiency
- a prior hypersensitivity reaction to MRI contrast
Key Trial Info
Start Date :
February 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04134910
Start Date
February 3 2025
End Date
February 3 2025
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, United States, 19104-4551